Viewing Study NCT07288359

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:38 PM
Ignite Modification Date: 2026-02-12 @ 7:16 PM
Study NCT ID: NCT07288359
Status: RECRUITING
Last Update Posted: 2025-12-22
First Post: 2025-12-15
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced HR+/HER2- Breast Cancer View
None Advanced CCNE1-amplified Solid Tumors View
None Metastatic Castration-resistant Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None GVV858 View
None Fulvestrant View
None Letrozole View
None Breast Cancer View
None CCNE1 amplification View
None Prostate Cancer View